13F
← All fund report cards

PRICE T ROWE ASSOCIATES INC /MD/

13F equity value
$865M
Positions
3,133
Top 10 concentration
34.4%
Quarters / total new picks
32 / 1,276
13F equity value over time
$0M$556B$1.1T2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +5.2% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 56.2% of quarters (excess t = 1.71, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+3.6%
t-stat
1.71
Quarterly win rate
56%
Annualized excess
+7.5%
$1 → follow vs universe
$3.56 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.05820180630: follow 0.98020180930: follow 1.11420181231: follow 1.04420190331: follow 1.03220190630: follow 1.06820190930: follow 1.37520191231: follow 1.29020200331: follow 1.67020200630: follow 2.05320200930: follow 2.94120201231: follow 2.74820210331: follow 2.64920210630: follow 3.14020210930: follow 2.47320211231: follow 1.70220220331: follow 2.16120220630: follow 1.87420220930: follow 1.95620221231: follow 1.80420230331: follow 1.97720230630: follow 1.80120230930: follow 2.30320231231: follow 2.51520240331: follow 2.57120240630: follow 2.92820240930: follow 2.95120241231: follow 2.82320250331: follow 3.04820250630: follow 2.96820250930: follow 3.45420251231: follow 3.556 0.84 2.34 3.84 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 3133 · 2026 Q1

Ticker Value Weight QoQ
NVDA $65M
7.5%
HOLD
AAPL $51M
5.9%
HOLD
MSFT $43M
5.0%
TRIM
AVGO $26M
3.0%
HOLD
AMZN $26M
3.0%
TRIM
GOOGL $23M
2.7%
TRIM
GOOG $19M
2.3%
TRIM
META $19M
2.2%
TRIM
LLY $13M
1.5%
TRIM
V $12M
1.4%
HOLD
NFLX $10M
1.1%
ADD
MA $9M
1.1%
TRIM
TSLA $9M
1.1%
TRIM
JPM $8M
0.9%
HOLD
GE $7M
0.8%
TRIM
COP $6M
0.7%
ADD
TMUS $6M
0.7%
ADD
AMD $6M
0.7%
ADD
ISRG $6M
0.7%
HOLD
UNH $6M
0.7%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.